A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908). (Q36725445)
Jump to navigation
Jump to search
scientific article published on 10 December 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908). |
scientific article published on 10 December 2015 |
Statements
1 reference
A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908). (English)
1 reference
Martin S Tallman
1 reference
Hillard M Lazarus
1 reference
Selina M Luger
1 reference
Mark R Litzow
1 reference
Timothy G Call
1 reference
Clive S Zent
1 reference
Xin Victoria Wang
1 reference
Rhett P Ketterling
1 reference
Curtis A Hanson
1 reference
Edward N Libby
1 reference
Jacqueline C Barrientos
1 reference
Julie E Chang
1 reference
Jane J Liu
1 reference
Alejandro R Calvo
1 reference
Jacob M Rowe
1 reference
10 December 2015
1 reference
1 reference
308-312
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference